Galmed Pharmaceuticals Ltd.
EOCN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001595353
No open-market purchases or sales by Galmed Pharmaceuticals Ltd. insiders were filed in the last 90 days; 14 institutions reported holding it in 13F filings for Q2 2026, worth $85.9K in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Galmed Pharmaceuticals Ltd. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 22
- −3 vs. Q3 2022
- Shares held
- 2.43M
- −159.4K (−6.2%) vs. Q3 2022
- Total value
- $1.21M
- +$410.4K (+51.1%) vs. Q3 2022
- New holders
- 4
- 2 more added
- Sold out
- 7
- 11 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting EOCN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 14 | $85.9K |
| Q1 2026 | 16 | $71.2K |
| Q4 2025 | 17 | $166.4K |
| Q3 2025 | 14 | $102.0K |
| Q2 2025 | 15 | $140.2K |
| Q1 2025 | 13 | $80.4K |
| Q4 2024 | 12 | $142.8K |
| Q3 2024 | 10 | $38.3K |
| Q2 2024 | 13 | $112.9K |
| Q1 2024 | 13 | $57.6K |
| Q4 2023 | 14 | $248.8K |
| Q3 2023 | 17 | $428.2K |
| Q2 2023 | 12 | $419.1K |
| Q1 2023 | 21 | $878.3K |
| Q4 2022 | 22 | $1.21M |
| Q3 2022 | 25 | $803.6K |
| Q2 2022 | 22 | $1.70M |
| Q1 2022 | 23 | $4.47M |
| Q4 2021 | 24 | $7.05M |
| Q3 2021 | 26 | $11.8M |
| Q2 2021 | 25 | $14.6M |
| Q1 2021 | 30 | $19.4M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Galmed Pharmaceuticals Ltd.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Benjamin F. Edwards & Company, Inc. | 200 | $0 | 0.00% | +200 | New |
| Bourgeon Capital Management LLC | 500 | $250 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 600 | $300 | 0.00% | −13,690−95.8% | Reduced |
| TD Waterhouse Canada Inc. | 1,000 | $972 | 0.00% | 00.0% | Unchanged |
| Accurate Wealth Management, LLC | 1,113 | $1.00K | 0.00% | +1,113 | New |
| Federation des caisses Desjardins du Quebec | 2,500 | $1.25K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 3,050 | $1.52K | 0.00% | −1,000−24.7% | Reduced |
| TSFG, LLC | 3,000 | $2.00K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 10,000 | $5.00K | 0.00% | −10.0% | Reduced |
| Ground Swell Capital, LLC | 10,359 | $5.18K | 0.02% | −2,669−20.5% | Reduced |
| StoneX Group Inc. | 10,562 | $5.28K | 0.00% | +10,562 | New |
| Belpointe Asset Management LLC | 14,050 | $7.03K | 0.00% | +14,050 | New |
| UBS Group AG | 21,432 | $10.7K | 0.00% | −5,554−20.6% | Reduced |
| Geode Capital Management, LLC | 27,177 | $13.0K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 27,223 | $13.6K | 0.00% | +13,319+95.8% | Added |
| Raymond James Financial Services Advisors, Inc. | 27,900 | $13.9K | 0.00% | −30,410−52.2% | Reduced |
| Cambridge Investment Research Advisors, Inc. | 28,500 | $14.0K | 0.00% | −6,615−18.8% | Reduced |
| Western Wealth Management, LLC | 29,537 | $14.8K | 0.00% | −29,537−50.0% | Reduced |
| Raymond James & Associates | 138,040 | $69.0K | 0.00% | −17,900−11.5% | Reduced |
| Millennium Management LLC | 149,217 | $75.0K | 0.00% | +102,351+218.4% | Added |
| Morgan Stanley | 180,724 | $90.4K | 0.00% | −8,896−4.7% | Reduced |
| BVF Inc | 1,739,670 | $869.8K | 0.04% | −60,024−3.3% | Reduced |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −50,789−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −22,548−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −18,628−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −18,512−100.0% | Sold out |
| Brave Asset Management Inc | 0 | $0 | 0.00% | −11,470−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −1,785−100.0% | Sold out |
| PYA Waltman Capital, LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |